CV Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

NET INCOME (LOSS) PER SHARE

NET INCOME (LOSS) PER SHARE

12 Months Ended

Dec. 31, 2020

NET LOSS PER SHARE

The Company computes basic net loss per share using the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares plus potential common shares. The Company's stock options, including those with performance conditions, are included in the calculation of diluted net loss per share using the treasury stock method when their effect is dilutive. Potential common shares are excluded from the calculation of diluted net loss per share when their effect is anti-dilutive.

The following common stock equivalents were not included in the calculation of net loss per diluted share because their effect were anti-dilutive (in thousands):


	For the years ended December 31,
	2020	2019
Stock options	20,225	18,105
Performance stock options	5,000	10,000
Total	25,225	28,105

The above table excludes 8,000,000 unvested performance stock options for the years ended December 31, 2020 and 2019, which vest upon the completion of future performance conditions.